Angelo Rigotti

487 total citations
18 papers, 209 citations indexed

About

Angelo Rigotti is a scholar working on Nephrology, Infectious Diseases and Oncology. According to data from OpenAlex, Angelo Rigotti has authored 18 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 8 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Angelo Rigotti's work include COVID-19 Clinical Research Studies (8 papers), Dialysis and Renal Disease Management (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Angelo Rigotti is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Dialysis and Renal Disease Management (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Angelo Rigotti collaborates with scholars based in Italy, Lebanon and San Marino. Angelo Rigotti's co-authors include Gianluigi Ardissino, Manuela Wally Ossola, Massimo Cugno, Giovanni Mosconi, Dino Gibertoni, Antonio Santoro, Paola Rucci, Andrea Buscaroli, Maria Pia Fantini and Chiara Reno and has published in prestigious journals such as PLoS ONE, Obstetrics and Gynecology and Nephrology Dialysis Transplantation.

In The Last Decade

Angelo Rigotti

17 papers receiving 207 citations

Peers

Angelo Rigotti

NEPHR

IMMUN

HEMAT

GENET

Özgür Akın Oto Türkiye

Ahmet Burak Dirim Türkiye

Bengt von Zur‐Mühlen Sweden

Laila‐Yasmin Mani Switzerland

Arabesque Parker Canada

Rekha Hans India

Charlotte Colosio France

Maud François France

Céline Desconclois France

Judith Schimpf Austria

Özgür Akın Oto Türkiye

Angelo Rigotti

58 ×0.7

NEPHR

38 ×0.5

IMMUN

70 ×1.1

18 ×0.4

HEMAT

6 ×0.2

GENET

Citations per year, relative to Angelo Rigotti Angelo Rigotti (= 1×) peers Özgür Akın Oto

Countries citing papers authored by Angelo Rigotti

Since Specialization

Citations

This map shows the geographic impact of Angelo Rigotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Rigotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Rigotti more than expected).

Fields of papers citing papers by Angelo Rigotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Rigotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Rigotti. The network helps show where Angelo Rigotti may publish in the future.

Co-authorship network of co-authors of Angelo Rigotti

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Rigotti. A scholar is included among the top collaborators of Angelo Rigotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Rigotti. Angelo Rigotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rigotti, Angelo, et al.. (2025). Saúde mental e envelhecimento saudável: as contribuições das práticas regulares de exercícios físicos sobre transtornos de ansiedade e depressão. Caderno Pedagógico. 22(9). e17864–e17864.

Donati, Gabriele, Lorenzo Gasperoni, Fulvia Zappulo, et al.. (2022). Anti-Inflammatory Approach in Chronic Dialysis Patients with SARS-CoV-2: ATA or PMMA Dialyzers?. Blood Purification. 52(2). 210–218. 5 indexed citations

Gasperoni, Lorenzo, et al.. (2022). Sotrovimab in SARS-COV-2 chronic hemodialysis patients in the Omicron era. Is intradialytic administration feasible? Report of 4 cases. Journal of Nephrology. 36(3). 669–672. 1 indexed citations

Gasperoni, Lorenzo, et al.. (2022). MO655: Anti-Inflammatory Approach in Chronic Dialysis Patients with SARS-CoV-2: ATA or PMMA Dialyzers?. Nephrology Dialysis Transplantation. 37(Supplement_3). 1 indexed citations

Mosconi, Giovanni, Simona Semprini, Gaetano La Manna, et al.. (2022). Efficacy of SARS-CoV-2 Vaccination in Dialysis Patients: Epidemiological Analysis and Evaluation of the Clinical Progress. Journal of Clinical Medicine. 11(16). 4723–4723. 10 indexed citations

Gibertoni, Dino, Chiara Reno, Paola Rucci, et al.. (2021). COVID-19 incidence and mortality in non-dialysis chronic kidney disease patients. PLoS ONE. 16(7). e0254525–e0254525. 40 indexed citations

Cappuccilli, Maria, Simona Semprini, Giorgio Dirani, et al.. (2021). COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant Recipients. The Nephron journals/Nephron journals. 145(4). 363–370. 9 indexed citations

Gibertoni, Dino, Chiara Reno, Paola Rucci, et al.. (2021). COVID-19 Incidence and Mortality in Pre-Dialysis Chronic Kidney Disease Patients. SSRN Electronic Journal. 10 indexed citations

Cappuccilli, Maria, Simona Semprini, Elisabetta Fabbri, et al.. (2021). Persistence of Antibody Responses to the SARS-CoV-2 in Dialysis Patients and Renal Transplant Recipients Recovered from COVID-19. Pathogens. 10(10). 1289–1289. 2 indexed citations

10.

Santoro, Antonio, Dino Gibertoni, Paola Rucci, et al.. (2019). The PIRP project (Prevenzione Insufficienza Renale Progressiva): how to integrate hospital and community maintenance treatment for chronic kidney disease. Journal of Nephrology. 32(3). 417–427. 9 indexed citations

11.

Grimaldi, Daniela, et al.. (2018). [FSGS collapsing variant during anabolic steroid abuse: Case Report].. PubMed. 35(6). 1 indexed citations

12.

Mignani, Renzo, et al.. (2017). Different renal phenotypes in related adult males with Fabry disease with the same classic genotype. Molecular Genetics & Genomic Medicine. 5(4). 438–442. 6 indexed citations

13.

Gibertoni, Dino, Marcora Mandreoli, Paola Rucci, et al.. (2015). Excess mortality attributable to chronic kidney disease. Results from the PIRP project. Journal of Nephrology. 29(5). 663–671. 12 indexed citations

14.

Tassi, Cristina, et al.. (2014). Innovative therapeutic approach: Sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome. Transfusion and Apheresis Science. 51(2). 134–136. 18 indexed citations

15.

Frascà, Giovanni M., et al.. (2014). Post‐Dilution Hemodiafiltration With a Heparin‐Grafted Polyacrylonitrile Membrane. Therapeutic Apheresis and Dialysis. 19(2). 154–161. 10 indexed citations

16.

Ardissino, Gianluigi, et al.. (2013). Eculizumab for Atypical Hemolytic Uremic Syndrome in Pregnancy. Obstetrics and Gynecology. 122(2). 487–489. 55 indexed citations

17.

Mignani, Renzo, P. Preda, Antonio Granata, et al.. (2009). Isolated microalbuminuria as the first clinical presentation of Fabry disease in an adult heterozygous female. Clinical Kidney Journal. 2(6). 455–457. 2 indexed citations

18.

Pasquali, Stefano, L Cagnoli, C Rovinetti, Angelo Rigotti, & P Zucchelli. (1985). Plasma exchange therapy in rapidly progressive renal failure due to multiple myeloma.. PubMed. 8 Suppl 2. 27–30. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact